Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
vH75YsM6TFxjt678